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ABSTRACT
Huntington disease (HD) is a neurodegenerative
disorder that predominantly affects neurons of the
forebrain. We have applied the Illumina massively
parallel sequencing to deeply analyze the small
RNA populations of two different forebrain
areas, the frontal cortex (FC) and the striatum (ST)
of healthy individuals and individuals with HD.
More than 80% of the small-RNAs were annotated
as microRNAs (miRNAs) in all samples. Deep
sequencing revealed length and sequence hetero-
geneity (IsomiRs) for the vast majority of miRNAs.
Around 80–90% of the miRNAs presented modifica-
tions in the 30-terminus mainly in the form of
trimming and/or as nucleotide addition variants,
while the 50-terminus of the miRNAs was specially
protected from changes. Expression profiling
showed strong miRNA and isomiR expression de-
regulation in HD, most being common to both FC
and ST. The analysis of the upstream regulatory
regions in co-regulated miRNAs suggests a role
for RE1-Silencing Transcription Factor (REST) and
P53 in miRNAs downregulation in HD. The putative
targets of deregulated miRNAs and seed-region
IsomiRs strongly suggest that their altered expres-
sion contributes to the aberrant gene expression in
HD. Our results show that miRNA variability is a ubi-
quitous phenomenon in the adult human brain,
which may influence gene expression in physio-
logical and pathological conditions.
INTRODUCTION
Huntington’s disease (HD) is an autosomal dominant
neurodegenerative disease caused by a CAG repeat expan-
sion in the HTT (huntingtin) gene that encodes HTT.
Although HTT is ubiquitously expressed, patients with
HD show predominantly central nervous system (CNS)
manifestations, including abnormal motor symptoms, cog-
nitive decline and psychiatric disturbances. HD is
characterized by widespread mRNA misregulation, espe-
cially in the striatum and cortical regions (1). Such deregu-
lation is the result, in part, of aberrant nuclear localization
of the transcriptional repressor RE1-Silencing Trans-
cription Factor (REST) (2,3). This REST nuclear trans-
location leads to increased transcriptional repression of
BDNF, a REST target gene, therefore compromising
striatal neuronal survival. In addition to protein-coding
genes, recent reports have shown that REST controls
the expression of neuronal large (macroRNAs) and small
[microRNAs (miRNAs)] non-coding RNAs (4,5), with
various roles in gene expression modulation. Therefore,
aberrant expression of non-coding RNAs may have
indirect consequences in HD gene expression deregulation.
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the post-transcriptional regulation of gene expression
through sequence complementarity to open reading
frame (ORF) and 30untranslated regions (UTRs) of mes-
senger RNAs (mRNAs). This binding leads to target
mRNA degradation or translational inhibition. miRNAs
play important roles in organogenesis, metabolism and
neuronal development. Many miRNAs are selectively ex-
pressed in the brain and appear to regulate fundamental
neuronal processes, including the maintenance of the
neuronal transcriptome, dendrite outgrowth and
synaptic plasticity (6). In addition, miRNAs have been
shown to be essential for neuronal survival and alterations
in miRNA function have been involved in a number of
neurodegenerative processes (7,8). These alterations
comprise aberrant expression of miRNAs in the brain of
patients with neurodegenerative diseases (9–15) and
single-nucleotide polymorphisms (SNPs) (16) or a point
mutation (14) in the target 30UTR NA binding site.
Two main ﬁndings point to the possibility that small-
RNA silencing-dependent mechanisms participate in HD
neuropathology. First, increased repression by REST
leads to changes in the expression of speciﬁc neuronal
miRNAs in HD patients and HD mouse models (17,18).
Second, HTT interacts with Argonaute proteins, which
are key members of the RNA-induced silencing complex
(RISC). This interaction with the mutant HTT leads to a
reduced reporter gene silencing activity compared with the
wild-type HTT (19). Overall, these data strongly suggest
that alterations in miRNA-mediated post-transcriptional
regulation could be a mechanism contributing to mRNA
expression deregulation in HD.
Although alterations in miRNA expression have been
reported in brain samples of HD patients, a deep charac-
terization of miRNA proﬁling and sequence modiﬁcations
is lacking. The available high-throughput sequencing
technologies allow detection of the current reference
miRNA sequences residing in the miRBase and novel
miRNAs. This approach has also the potential to
uncover variations in the mature miRNA length, and en-
zymatic modiﬁcations such as RNA editing and 30 nucleo-
tide additions. The Illumina sequencing platform yields
several million sequences from a single ﬂow cell lane,
providing a high resolution. In the present study, we
used Illumina deep sequencing to extensively proﬁle and
identify disease-speciﬁc changes of small non-coding
RNAs that occur in the frontal cortex (FC) and the
striatum (ST), two brain areas affected in HD. Our
results show a strong deregulation of miRNA expression
in HD and highlight the potential importance of the large
number of modiﬁed mature miRNA sequences in the
physiology and pathology of the adult brain.
METHODS
Human brain samples
Patients with HD had suffered from a familial degenera-
tive disease characterized by involuntary muscle
movement, difﬁculties with speech, trouble swallowing
and walking and excessive blinking. This was followed
by abnormal behavior and cognitive impairment, continu-
ous falls and hypokinesia, leading to terminal
akinetic-rigid disorder. Genetic studies showed increased
CAG repetitions in the HTT gene in affected relatives or
an increased number of CAG nucleotides in affected
individuals. Neuroimaging [computed tomography (CT)
or magnetic resonance imaging (MRI) scans] disclosed
severe atrophy of the caudate and putamen and
moderate to severe cortical atrophy during the course of
the disease. Based on the clinical and genetic data, a diag-
nosis of HD was made during life in every case.
Brain samples corresponding to the frontal cortex (FC)
and the striatum (ST) (dorsal caudate) of HD patients
and controls were obtained from the Institute of
Neuropathology and the University of Barcelona Brain
Bank, after the informed consent of the patients or their
relatives and the approval of the local ethics committee
had been given (Supplementary Table S1). Cases with and
without clinical neurological disease were processed in the
same way, following the same sampling and staining
protocols. Gross atrophy was seen in HD cases. At
autopsy, half of each brain was ﬁxed in 4% buffered
formalin, whereas the other half was cut in coronal
sections 1cm thick, frozen on dry ice, and stored at
 80 C until use. The postmortem delay was between 3
and 17h. The neuropathological study was carried out
on dewaxed 4-mm-thick parafﬁn sections of the frontal
lobe (area 8), primary motor, primary sensory, parietal,
temporal superior, temporal inferior, anterior cingulated,
anterior insular and primary and associative visual
cortices; entorhinal cortex and hippocampus; head of the
caudate, medial caudate, putamen and globus pallidus;
medial and posterior thalamus; subthalamus; Meynert
nucleus; amygdala; midbrain (two levels); pons and
medulla oblongata; and cerebellar cortex and dentate
nucleus. The sections were stained with hematoxylin and
eosin and Klu ¨ ver–Barrera and processed for immunohis-
tochemistry to glial ﬁbrillary acidic protein (GFAP),
CD68 and Licopericum esculentum lectin for microglia;
Ab-amyloid; pan-tau, AT8 tau and phosphorylation-
speciﬁc tau Thr181, Ser202, Ser214, Ser262, Ser396 and
Ser422; aB-crystallin; a-synuclein; and ubiquitin.
The neuropathological examination in HD cases
revealed severe atrophy of the caudate and putamen, the
atrophy being more marked in the dorsal border, together
with cerebral cortical atrophy and enlargement of the
lateral ventricles. This was accompanied by marked
neuronal loss and astrocytic gliosis in the caudate and
putamen, globus pallidus and cerebral cortex. Individual
neurons in the cerebral cortex and striatum exhibited
ubiquitin-positive intranuclear inclusions typical of
diseases with CAG triplet expansions and ubiquitin-
positive neuritic processes in the same regions. After
neuropathological examination, HD cases were
categorized as stage 4 following Vonsattel classiﬁcation
(20,21).
RNA extraction and sequencing
Total RNA was isolated from  10mg of the different
brain areas using the miRNeasy kit (Qiagen) that
7220 Nucleic Acids Research, 2010,Vol.38, No. 20preserves small RNAs. Equal amounts of total RNA of
two equivalent patients and brain areas were mixed, giving
rise to a total of four samples (C-FC, HD-FC, C-ST and
HD-ST) showing RNA integrity numbers (RIN) between
6 and 7. A total of 5mg of small-RNA-enriched total RNA
was processed for Illumina sequencing. Brieﬂy, the pro-
cessing by Illumina consisted of the following successive
steps (22,23): acrylamide gel puriﬁcation of RNA bands
corresponding to the size range 18–30nt, ligation of 50 and
30 adapters to the RNA in two separate subsequent steps
each followed by acrylamide gel puriﬁcation, cDNA syn-
thesis followed by acrylamide gel puriﬁcation, and a ﬁnal
step of polymerase chain reaction (PCR) ampliﬁcation to
generate template library for cluster generation on a ﬂow
cell. After hybridization of the sequencing primer libraries
were sequenced it using a GAII instrument (Illumina). The
reads generated were 36-nt long and were analysed using
SeqBuster pipeline (24).
Pre-analysis of human brain sequencing data
Pre-analysis consists in the recognition and removal of the
adapter and the annotation of the sequences. Pre-analysis
was performed using a stand-alone version provided in
http://estivill_lab.crg.es/seqbuster (24). Out of a total of
several million reads, we discarded any reads without a
minimum of 10-nt linker subsequence directly adjoining
the insert, showing two or less mismatches. Following
the application of this ﬁlter, populations of 5914073;
5561686; 5125116 and 5855660 reads were recovered
in C-FC, C-ST, HD-FC and HD-ST samples, respectively.
Taking into account the unique sequences with more than
three counts, the total number of reads were 5827761;
5466923; 5041667 and 5759841. Then sequences were
mapped to human pre-miRNA and mature miRNA data-
bases provided in the miRBase (http://microrna.sanger.ac
.uk/sequences/, Release 14), and mRNA, ncRNA, repeats
and genome databases available at (http://hgdownload
.cse.ucsc.edu/goldenPath/hg18/bogZips/), using Mega
BLAST. For precursor miRNA annotation the following
parameters were conﬁgured (24): one mismatch, 3nt in the
30-addition variants and the priority degree equal to 3. For
miRNA and miRNA* annotation the following param-
eters were conﬁgured: one mismatch, 3nt in the 30 or
50-trimming variants, 3nt in the 30-addition variants, a
priority degree to 1 and 2 for miRNA and miRNAs* data-
bases, respectively, and the parental database was the pre-
cursor miRNA database. These options permitted
annotations of the following types of alignment: (i)
perfect match, where the sequence is completely identical
to the reference sequence; (ii) trimming at the 30-end of the
reference miRNA sequence, which is a miRNA variant
several nucleotides shorter or longer that matches to the
mature or precursor reference sequence, respectively;
(iii) trimming at the 50-end of the sequence, an analogous
case focused on the 50-end of the miRNA; (iv) nucleotide
additions at the 30-end of the sequence and (v) nucleotide
substitutions, showing nucleotide changes with respect to
the reference sequence. The parameters for the alignment
to the mRNA and genome databases allowed as much as
one mismatch and up to three nucleotide additions in the
30-terminus. The priority parameter was 4, 5, 6 and 7 for
mRNA, ncRNA, repeats and genome databases, respect-
ively (24).
Analysis of miRNA variability (IsomiRs)
For deep characterization of miRNA, variants we applied
several ﬁlters. First, the sequences considered in the
analysis presented a frequency above 3. Second, 10 was
chosen as the ‘Contribution Cut-Off’ parameter, meaning
that every isomiR considered in the analysis contributes
by more than a 10% to the total number of variants
annotated in the same miRNA locus. Third, we applied
the Z-score option to exclude sequencing errors as the
possible cause of the nucleotide changes observed in
some variants (24). Annotated miRNAs and IsomiRs
with the corresponding counts are available at
http://estivill_lab.crg.es/Marti_etal/. Four ﬁles are avail-
able containing the data set of control FC (C_FC),
control ST (C_ST), HD FC (HD_FC) and HD FC
(HD_ST) samples.
Novel miRNA prediction
The ‘human miRNA prediction’ package in the SeqBuster
pipeline (24) uses the algorithm described in the microPred
pipeline (25) that is based on a non-comparative compu-
tational method for the effective identiﬁcation of
pre-miRNAs among the hairpin secondary structures pre-
dicted from the human genome. A test input ﬁle has to be
provided containing all sequences for which the analysis is
going to be performed.
SNP analysis in miRNAs
The ‘SNP analysis’ package is offered by SeqBuster in
the ‘Download’ section of the web server to be run in
the local machine (24). This package contains genomic
coordinates for available SNPs (https://hgdownload.cse
.ucsc.edu/downloads/html). The algorithm produces a
table showing all the sequences that have a nucleotide
substitution event at the same position where an SNP
has been detected.
Differential expression analysis
The sequencing performance in the samples to be
compared was evaluated using the ‘Sequencing Capacity’
package in the ‘Basic Analysis’ module of SeqBuster with
default parameters (24). In this package, the Willcoxon
test was applied to determine statistically signiﬁcant dif-
ferences in the frequency distribution between samples.
Two types of differential expression analyses were per-
formed, that included different types of sequences:
(i) the different miRNA loci were containing all the se-
quences mapping to each locus; and (ii) 50-trimming and
nucleotide substitution IsomiRs affecting the seed region
of the miRNA. To perform these analyses several options
and ﬁlters were applied. First, the frequency was
normalized to reads per million (RPM). Second, the
Z-test (26) was applied to show statistical signiﬁcance in
the differential expression. Third, the Benajmini and
Hochberg method was applied to correct the P-value
Nucleic Acids Research, 2010,Vol.38, No. 20 7221assigned by the Z-test. Fourth, in analyzing the seed
region variants, 10 was chosen as the ‘Contribution
Cut-Off’ value (24). Fifth, we applied the Z-score option
to exclude sequencing errors as the possible cause of the
nucleotide changes observed in the isomiR (27). In the
output resulting from the analysis we only showed se-
quences with a total count contribution above 50, con-
sidered as the sum of the frequencies of the two samples
being compared.
Microarray preparation and statistical analysis
Agilent Human miRNA microarrays (G4470B), contain-
ing 13737 probes, were used to analyze independent
samples from the FC and the ST of four control individ-
uals and four HD patients (Supplementary Table S1).
Brieﬂy, 500ng of total RNA from each sample were chem-
ically labeled by dephosphorylating using calf intestinal
alkaline phosphatase (CIP) and ligating Cyanine3-pCp
by a T4-RNA ligase using Agilent miRNA Complete
Labeling and Hyb Kit (p/n5190-0456). Labeled samples
were dried and resuspended in 18ml of nuclease-free
water and co-hybridized with in situ hybridization buffer
(Agilent) for 20h at 55 C and washed at room tempera-
ture for 5min in Gene Expression Wash Buffer 1 (Agilent)
and 5min at 37 C in Gene Expression Wash Buffer 2
(Agilent). The images were generated on a confocal micro-
array scanner (G2505B, Agilent) at 5um resolution and
quantiﬁed using Feature Extraction (Agilent). Extracted
log2-transformed intensities were quantile normalized to
make all data comparable.
To assess differential expression, signiﬁcance analysis
of microarrays (SAM) was used (28). Results of SAM
analysis were corrected for multiple testing according to
the false discovery rate (FDR) method (29). Probes with
FDR-adjusted P-value below 5% and additionally a fold
change exceeding 1,2 in absolute value were selected as the
relevant ones. Final relative expression values were
computed by taking the median log2 ratio of the respect-
ive probes per each miRNA. All statistical analyses were
performed with Bioconductor project (version 2.3) in the
R statistical environment (30).
Quantitative real-time PCR
A total of 14 differentialy expressed miRNAs found con-
cordant both by sequencing and microarray analyses data
were conﬁrmed by real-time quantitative reverse transcrip-
tion PCR (qRT-PCR) using TaqMan MicroRNA assays
(Applied Biosystems) in striatal samples of ﬁve control
individuals and ﬁve HD patients. Total RNA was used
as a template to generate speciﬁc ﬁrst-strand complemen-
tary DNA (cDNA) for each miRNA using Taqman
speciﬁc miRNA retrotranscription kit. qRT-PCR was
performed following manufacturer’s instructions using
the ABI PRISM 7900HT sequence detection system
(Applied Biosystems). Relative quantiﬁcation was
calculated with the 2  Ct method (31) using the
snRNA, RNU58B as an endogenous control. Statistical
signiﬁcance and fold change were calculated using linear
mixed-effects models (LMM) that contemplate random
effects accounting for the different sources of variation:
technical (qRT-PCRs) and biological replicates (32).
Functional enrichment analysis
We used the TargetScan algorithm that predicts biological
targets by searching for the presence of conserved 8-mer
and 7-mer sites that match the seed region of each isomiR
(33,34). We used the TargetScan custom option (www.
targetscan.org) to predict mRNA targets of the seed
region IsomiRs differentialy expressed between libraries.
The mRNA targets for the corresponding differentialy
expressed reference miRNAs were identiﬁed through
the SeqBuster ‘Target prediction’ module using the
TargetScan algorithm. Since the cooperative action of
multiple miRNAs can be multiplicative and sometimes
synergistic (33), mRNAs with more predicted target sites
for co-expressed IsomiRs or reference-miRNAs should
be more drastically affected. Therefore, we considered
targets predicted by three or more HD-FC or HD-ST
co-regulated IsomiRs or reference miRNAs. Then, in-
genuity pathway analysis (IPA) was used to explore
subsets of genes exclusively targeted by HD-co-regulated
IsomiRs and those affected by the IsomiRs and
reference-miRNAs. In the IPA ﬁlters, we only considered
the brain and CNS cell lines as target tissues. The P-value
associated with a biological process is calculated with the
right-tailed Fisher’s exact test, considering the number of
functions/pathways/lists eligible molecules that participate
in that annotation, the total number of knowledge base
molecules known to be associated with that function, the
total number of functions/pathways/lists eligible mol-
ecules and the total number of genes in the Reference
Set (IPA tutorial).
Analysis of the co-regulated miRNA promoter regions
We compared and characterized the promoter regions of
miRNAs with similar expression patterns, using the algo-
rithm described by Blanco et al. (35). The package requires
a test ﬁle containing a list of the co-regulated miRNAs
and a list with all the expressed miRNAs. To identify a
possible signiﬁcant enrichment of cis-regulatory elements
in co-regulated miRNAs the algorithm assigns a P-value
using the permutation-based simulation.
RESULTS
Overview of small RNA sequencing and annotation
In the present study, we chose to characterize small RNAs
in the FC and the dorsal caudate nucleus of the ST, two
brain areas strongly affected in HD that showed a differ-
ential pattern of neuronal loss. Total RNA was isolated
from these brain areas in two HD patients and two
nonaffected individuals showing similar quality standards
(see ‘Methods’ section). Equivalent amounts of RNA were
mixed from the FC or the ST, which resulted in four small
RNA libraries from the FC and the ST of two patients
with HD and two nonaffected individuals.
Sequencing of small RNAs yielded 6788286; 5934411;
6495715; and 6 776627 unﬁltered sequence reads from
7222 Nucleic Acids Research, 2010,Vol.38, No. 20control FC (C-FC), HD-FC (HD-FC), control ST (C-ST)
and HD ST (HD-ST), respectively. Any sequence
observed more than three times was considered a reliable
representation of a small RNA molecule. After removal of
reads containing ambiguous base calls, unique sequences
remained between 60669 (C-FC), 61416 (HD-FC) 68168
(C-ST) and 72475 (HD-ST) (Table 1). After mapping to
the genome the total of unique sequences represented
between 5000000 and 6000000 reads. Most reads
mapped the genome, with <9–16% of the sequences not
being identiﬁed (Table 1).
Sequences were annotated based on the overlap
with publicly available genome annotations, including
miRNA, tRNAs, rRNAs, other small RNAs and
genomic repeats. miRNAs were the most abundant class
of small RNAs (80–85%), spanning the entire range of
expression. Sequences deriving from 372–392 distinct
miRNA genes were identiﬁed in the different libraries,
showing a sequence length distribution with a sharp
peak in the 22nt length (Supplementary Figure S1).
Let-7 was the most abundant family of miRNAs, with
sequence counts up to 600000. The top conserved
miRNAs occupied 40–50% of the total miRNA reads
(Supplementary Table S2). However, human-speciﬁc
miRNAs were expressed at a signiﬁcantly lower level,
constituting around 0.1% of the total number of reads.
This agrees with previous reports showing that the
miRNA abundance is linked to the extent of conservation
(36).
To identify putative new miRNAs among the sequences
mapped onto the genome, we used the microPred
pipeline (25). This is a noncomparative computational
tool developed for the identiﬁcation of miRNAs from a
pool of sequenced RNA transcripts resulting from deep
sequencing. Between 846 and 1094 different sequences in
each sample were found to statistically fulﬁll the structural
features that deﬁne a miRNA, including the ability
to form hairpin secondary structures that showed Dicer
processing features. Approximately two-thirds of the se-
quences corresponded to slight length variations of a
single representative. Therefore, 226–375 new putative
miRNAs were found in each sample, being 85 common
to all samples (Supplementary Table S3). Functional
studies are required to demonstrate that these new
putative miRNAs can regulate gene expression through
the RISC silencing machinery.
miRNA variability is ubiquitous in control and HD
brain samples
Variants of the mature miRNA have been referred to as
IsomiRs (37). In the present study, 20000–23000 different
variants (frequency >3) were found in every sample.
Furthermore, most of the sequences mapping onto
miRNA database (reference miRNAs and IsomiRs)
showed from 3–50 counts (Supplementary Figure S2). It
has been proposed that much of the miRNA modiﬁcations
can be explained by variability in either Dicer1 or Drosha
cleavage positions at the 50-end or 30-end of the
miRNA-precursor (50-o r3 0-trimming variants) during
miRNA biogenesis (37). Another type of variability is
related with pri-miRNA post-trancriptional editing as a
consequence of adenosine or cytidine desaminase activities
(nucleotide substitution variants), which can be detected
at different positions of the mature miRNA (38–42).
Besides, nucleotide additions at the 30-end of the mature
miRNA (30-addition variants) have also been reported as
the most common form of miRNA enzymatic modiﬁca-
tion (37,41). The  380 miRNAs detected in every sample
displayed IsomiRs and only two and ﬁve miRNAs
remained invariable in FC and ST libraries respectivelly
(Table S4). The frequency of these invariable miRNAs
was very low, suggesting that the lack of variants may
be due to the low abundance rather than a selective pro-
tection from modiﬁcations.
In all the libraries, variability was detected mainly as the
result of modiﬁcations in the cleavage position at the
30-end of the pri-miRNA. In this case, a considerable pro-
portion of miRNAs presented 2 or more 30-trimming
variants (Figure 1A). However, for the 50-trimming
variants, additions in the 30-end of the mature miRNA,
or single-nucleotide substitutions with respect to the ref-
erence sequence, the majority of the miRNAs presented
IsomiRs with only one change.
Taking into account the possible physiological signiﬁ-
cance of an isomiR, it should be considered how the new
variant affects the regulation of a target mRNA. miRNAs
interact with their mRNA targets by imperfect base
pairing following a set of rules that have been identiﬁed
in experimental and bioinformatic analyses (43,44). These
include perfect binding of the 50-seed (nt 2–8), mismatches
at the central region of the miRNA (nt 10–12) and a rea-
sonable complementariety with the 30 half of the miRNA,
specially positions 13–16. It should be stressed that these
requirements are not completely understood as target
Table 1. Distribution of the different types of sequences in control
and Huntington disease brain samples
Database Data C-FC HD-FC C-ST HD-ST
miRNAs Frequency 5035324 4019202 4558525 4574587
Unique sequences 20925 19683 23198 21102
miRNA* Frequency 21544 27039 6729 23193
Unique sequences 840 829 405 837
Pre-miRNAs Frequency 19061 19283 18189 24084
Unique sequences 1036 1347 1083 1654
mRNAs Frequency 100651 91681 126949 87436
Unique sequences 4582 3857 4671 4108
Predicted
miRNAs
Frequency 108921 77386 111211 70278
Unique sequences 1094 846 1083 883
Sn-RNAs+ Frequency 0 225 103 280
Unique sequences 0 45 23 56
tss+ Frequency 0 37 0 33
Unique sequences 0 7 0 9
Genome Frequency 871 1051 321 1403
Unique sequences 87 208 57 253
Unmapped Frequency 541389 805763 644896 978547
Unique sequences 32105 34594 37649 43573
Total Frequency 5827761 5041667 5466923 5759841
Unique sequences 60669 61416 68168 72475
Sequences showing a frequency >3 are considered.
miRNA*, passenger strand of the miRNA duplex that is less stable;
+, sense strand; Sn, small non-coding RNAs; tss, transcription start site
small RNA.
Nucleic Acids Research, 2010,Vol.38, No. 20 7223prediction algorithms have very high false-negative and
false-positive rates. However, the requirements for target
recognition favor the possibility that the identiﬁed
miRNA variants target new mRNAs. In addition, since
the variant and the reference miRNA sequences are very
similar, it is likely that both small RNAs compete for a
number of target mRNAs. Thus, to evaluate the possible
relevance of each variant, we analyzed the frequency of
each isomiR with respect to that of reference miRNA
(Figure 1B). The majority of the nucleotide substitution
or 50-trimming variants showed a low frequency compared
to that of the reference miRNAs. However, variants af-
fecting the 30-terminus of miRNAs, especially the
30-trimming variants, showed a variable proportion with
respect to reference miRNAs. These results highlight the
possibility that the deregulation in the expression of nu-
cleotide substitution and 50-trimming IsomiRs could have
more dramatic physiological consequences. The large
abundance of some of the variants compared with the
correspondent reference miRNA (over 80%) indicates
that these IsomiRs should be considered as the reference
miRNA, at least in the human brain. In some cases, such
as miR-1291, miR-320c and miR-1260, the reference
miRNA sequence was not even detected (see examples in
Supplementary Table S5).
To gain insights into the possible relevance of the
IsomiRs as small silencing RNAs we evaluated the
presence of such variants in Ago immunoprecipitates
(Ago-IP). We analyzed publicly available sequencing
small-RNAs data sets (GEO database at http://www
.ncbi.nlm.nih.gov/geo/) of human HEK293 Ago1- and
Ago2-IP and mouse embryonic brain Ago1-IPs. We
detected the four types of IsomiRs in all the Ago-IPs
(Supplementary Figure S3). Furthermore, some of the
IsomiRs found in the Ago-IPs were also detected in the
sequenced brain samples (see examples in Supplementary
Figure S3). In addition, the 30-trimming and the
30-addition variants were the most abundant, similarly to
the analysis of total small-RNAs in the human brain
samples (Figure 1). These results show that IsomiRs are
incorporated into the Ago silencing complexes and
strongly support the idea that the variants are functional.
We analyzed the positions and nucleotides involved in
the different types of variants. Most 30-trimming variants
Figure 1. Histogram displaying the percentage of miRNAs with different types of IsomiRs (50-trimming, 30-trimming, 30-additions and nucleotide
substitutions), in C-FC (1), HD-FC (2), C-ST (3) and HD-ST (4) small RNA libraries. In this analysis, IsomiRs with frequencies >10 were
considered. For every type of variability, the histogram shows the proportion of miRNAs presenting one (white), two (gray) or more than two
(black) IsomiRs (A). An example of a miRNA (miR-124) displaying two 50-trimming variants (T1 and T2) is shown below. Arrows in the precursor
miRNA (Pre-miR-124) point the beginning of each isomiR. The histogram in (B) shows the abundance of the IsomiRs with respect to the corres-
ponding reference miRNA, for every type of variability. The ﬁve gray color intensities from dark to light indicate the frequency of the isomiR
with respect to the reference miRNA: <20%; 20–40%; 40–60%; 60–80% and >80%. The example below shows a 30-trimming variant (T1) with a
relative abundance with respect to the reference miRNA (miR-103) of around 40%. The arrow in Pre-miR-103 points the site where the 30-trimming
variant ends.
7224 Nucleic Acids Research, 2010,Vol.38, No. 20involved positions  1 (1nt upstream) and+1 (1nt down-
stream) of the 30-end of the reference miRNA, while the
majority of the 50-trimming variants involved the position
+1 of the 50-terminus of the reference miRNA, matching
the miRNA precursor (Figure 2A and B). Different nu-
cleotides at different positions were preferentially involved
in 30-o r5 0-trimming variants, which suggests a predilec-
tion of the dicing machinery for a nucleotide in a selective
position. In addition, the vast majority of 30-addition
variants consisted in a single A or U addition to the
30-end of the mature miRNA (Figure 2C), in accordance
with other reports (37,41).
An increasing number of studies have revealed nucleo-
tide substitutions as a possible source of IsomiRs, which
have been shown as the result of post-transcriptional
modiﬁcations or RNA-editing, rather than sequencing
technical artifacts (45–48). Illumina sequencing error
rates have been previously calculated for every position
of the sequence and every type of nucleotide change, in
genomic libraries (27). Therefore, in the analysis of the
nucleotide substitution variants, we only considered the
nucleotide modifcations signiﬁcantly different from these
error rates (see ‘Methods’ section). Under these condi-
tions,  35% of the miRNAs detected in each library
presented nucleotide substitution variants (Figure 1).
Table S6 shows the list of the nucleotide modifﬁcations
at different positions of the reference miRNA, commonly
detected in the four sequenced samples. We analyzed if
these nucleotide substitution variants could correspond
to SNPs. To this end, we compared the chromosome
coordinates of all available SNPs with those of the nucleo-
tide substitution variants. We found that miR-219-5p
Figure 2. Percentage of miRNAs with 50-trimming variants (A), 30-trimming variants (B) and 30-addition variants (C) in C-FC (1), HD-FC (2), C-ST
(3) and HD-ST (4) small RNA samples, according to the type and position of the nucleotide involved. In this analysis, IsomiRs with frequencies >10
were considered. Pre-miRNA slicing occurring at different positions upstream or downstream of the reference miRNA extremes (50- and 30-) is
indicated by  3 to –1 and+1 to+3, respectively (A, B). In the 30-addition variants (C), 1, 2 and 3 indicate the number of nucleotides added to the
30-terminus of the miRNA. In the upper part of each panel, a scheme of miRNA is shown. The part of the sequence in black corresponds to the
mature reference miRNA and the part in gray highlights the precursor sequence (A, B) or the nucleotides added in the 30-addition variants (C). The
orange arrows and box highlight the nucleotides being examined in the histogram below. The size of the arrow is proportional to the percentage
trimming variants at the signaled position. The color pattern of the bars indicates the nucleotides involved in the trimming variants at every position:
A (red), U (blue), C (green) and G (orange). Signiﬁcant bias toward a nucleotide involved in the trimming variant is shown with a white asterisk.
Below each histogram an example of a variant is shown in a gray box. The attached gray arrow indicates the speciﬁc type of IsomiR, within the
histogram, being analyzed.
Nucleic Acids Research, 2010,Vol.38, No. 20 7225presented variants (frequency  10) that matched with an
SNP in dbSNP; however, the frequency of these IsomiRs
was very low compared with the reference miRNA
(Supplementary Table S7). This miRNA presented
additional patterns of nucleotide substitution at the
same positions. This suggests that the vast majority of
the nucleotide substitution IsomiRs are likely post-
transcriptional.
Nucleotide modiﬁcations affecting the seed region (nu-
cleotides 2–8) are of particular interest given the essential
role of this fragment in target gene recognition and expres-
sion regulation. The majority of the miRNAs with
IsomiRs in the seed region, presented nt-modiﬁcations in
positions 5–8 (Figure 3). In the seed region, A to G nu-
cleotide changes (potential A to I editing) were observed in
a number of miRNAs. These were particularly abundant
at position 5 of the miR-411 and miR-379, as previously
described (47). Other common examples included an A to
G change in position 6 of all miRNAs of the cluster
miR-376a, 376-b and 376-c, in agreement with previous
reports (40). miR-320b and miR-320c are interesting
examples to highlight, since they present nucleotide sub-
stitution variants at several positions of the mature
miRNA (Supplementary Table S6). The detection of the
majority of miR-320c variants was conﬁrmed in the
re-analysis of small RNAs sequencing data of human em-
bryonic stem cells [(37); data not shown]. In addition to
the nucleotides belonging to the seed region, other
strongly invariable positions belong to the 30 half of the
miRNA, whose complementariety with target mRNAs is
an important determinant for interaction stabilization (44)
(Figure 3).
miRNA transcriptome deregulation in HD samples
To contrast small RNA expression between biologically
comparable samples, similar sequencing efﬁciencies
should be considered. To evaluate the sequencing per-
formance, the total number of counts for every unique
read in each sample was ordered according to decreasing
frequencies (Supplementary Figure S4). The frequency
distribution of the different reads showed no statistical
differences between the samples (Willcoxon test,
P>0.05), making them comparable for differential ex-
pression analysis.
Figure 4 shows an overall view of the expression levels
of all the different sequences (gray spots) mapping onto
diverse miRNA loci (black spots) in HD-FC (y-axis) and
HD-ST (x-axis). A considerable number of miRNAs loci
were commonly deregulated in HD-FC and HD-ST (black
spots in the upper right and lower left squares, respective-
ly). To identify the miRNAs signiﬁcantly deregulated in
HD, we chose the Z-test (26), since it is the most restrictive
test used for evaluation of differentially expressed se-
quences in high-throughput sequencing methodologies.
Furthermore, to control the FDR the P-value assigned
by the statistical test was corrected applying the
Benjamini and Hochberg method (29). A total of 102
upregulated miRNAs [ratio >1.2; P <0.05; normalized
frequency (HD-FC+C-FC) >50] and 58 downregulated
miRNAs [ratio <–1,2 and P<0.05; normalized frequency
(HD-FC+C-FC) >50] were detected in the HD-FC
library. A similar approach in the HD-ST, showed 69 sig-
niﬁcantly upregulated miRNAs and 62 downregulated
miRNAs (Supplementary Tables S8 and S9). The
Figure 3. Percentage of miRNAs with nucleotide substitution variants, according to the nucleotide position. A scheme of the mature miRNA
appears in the upper part of the ﬁgure showing the main regions involved in 30-UTR gene targeting: 50-seed (nt 2–8) the cleavage (nt 10–12) and
anchor (nt 13–16) sites. A gray square highlights the less variable positions along the miRNA. The color pattern in the bars indicates the proportion
of a speciﬁc type of nucleotide present in the isomiR, at every position: A (red), U (blue), C (green) and G (orange). In this analysis, nucleotide
substitution variants with more than 50 counts in each library are considered.
7226 Nucleic Acids Research, 2010,Vol.38, No. 20majority (55–80%) of the HD deregulated miRNAs were
common between FC and ST samples. Interestingly, the
HD-FC presented an increased number of upregulated
miRNAs (2.5-fold) that were not signiﬁcantly altered in
the HD-ST.
To identify the miRNA most likely relevant in HD we
performed miRNA arrays of FC and ST in four control
individuals and four HD patients. Considering an
FDR-adjusted P-value below 5% and a fold expression
change above 1.2 or below  1.2 in absolute value, 19
upregulated and 14 downregulated miRNAs, common to
the FC and the ST were conﬁrmed (Table 2). Selected
miRNAs (seven upregulated and seven downregulated)
were further validated using Taqman assays in ST
samples in ﬁve control individuals and ﬁve HD patients.
It should be taken into consideration that these tech-
niques, differing from sequencing strategies, are most fa-
vorable for the detection of the reference miRNAs and
may not be optimal for the detection of IsomiRs.
The differential expression analysis of the sequenced
samples conﬁrmed the expression pattern of 9 out of 11
miRNA (Supplementary Table S10), whose expression
was altered in the FC of HD patients in two previous
studies (17,18). In addition, the majority of the reported
miRNAs deregulated in other neurodegenerative disorders
(Alzheimer’s disease, Parkinson’s disease, Prion disease
and spinocerebellar ataxia type 1) were altered in the
HD sequenced samples (Supplementary Table S11).
Furthermore, a fraction of these miRNAs showed an ex-
pression deregulation pattern similar to that reported in
the other neurodegenerative diseases, indicating that they
may participate in gene expression deregulation
underlying common processes in neurodegeneration.
When studying the correlation between the expres-
sion pattern of all IsomiRs and the corresponding
reference miRNA our analysis showed that the majority
(80%) of HD-upregulated 30-o r5 0-IsomiRs displayed
an upregulation of the corresponding reference miRNA.
A similar result was obtained when considering
the downregulated reference IsomiRs (Supplementary
Table S12). These results suggest that the mechanisms
modulating the degree of expression of the IsomiRs and
the corresponding miRNAs are parallel in most cases.
However, a few sequences mapping on the same miRNA
were discordant, presenting the reference miRNA and the
isomiR an opposite expression pattern in HD. The
majority of these discordant IsomiRs were 30-variants
(30-trimming and 30-addition variants). Whether selective
forms of a miRNA are relevant in HD and how these
variants are selectively deregulated in HD deserve
further research.
Since the seed region is essential in the recognition and
expression modulation of target miRNAs we analyzed
HD-deregulated 50-trimming variants and nucleotide sub-
stitution variants involving any nucleotide change in pos-
itions 2–8 of the reference miRNA (Table 3). A total of 23
seed-region IsomiRs were deregulated in HD FC and/or
ST, that corresponded to 18 different miRNAs. Of these,
miR-935, miR-139-3p, miR-1307, miR-1308, miR-411 and
miR-142-5p variants can be considered the only represen-
tatives among all the IsomiRs mapping onto the same
locus. The rest of the seed-region deregulated IsomiRs
showed a varying proportion (10–50%) with respect to
that of the reference or the most abundant variant
mapping onto the same locus.
The REST transcription factor mis-function has been
considered to play a major role in HD (2–3). We
analyzed whether miRNAs that are potentially regulated
by REST showed differential expression in our sequencing
libraries. For this analysis we considered miRNAs with
known motifs for REST (4,17,49,50), which were
detected at frequencies above 10 in all the samples
(a total of 30 miRNAs). It is worth to mention that 16
(ST) and 19 (FC) out of the 30 REST modulated
Figure 4. Differential expression in HD-ST (x-axis) and HD-FC (y-axis) samples. Black spots show the miRNA loci and gray spots show all the
sequences (reference miRNAs and isomiRS) mapping onto the miRNA loci. The darker and lighter lines mark the limits of expression fold changes
in HD versus control samples above 1.2 and below –1.2, respectively.
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samples (Table 4). Interestingly, miR-9 in HD-FC and
miR-29b in HD-ST presented discordant up- and
downregulated variants, which highlights the putative
relevance of the different types of IsomiRs in the context
of HD. Considering all the deregulated REST target
miRNAs, the number of HD downregulated miRNAs
was twice the amount that what would be expected by
chance, both in HD-FC (P=0.004, Boostrapping
method) and HD-ST (P=0.003). Given that REST is a
transcriptional repressor, the enrichment in repressed
REST target miRNAs agrees with a major role of this
transcription factor in miRNA dysregulation in HD. To
address whether other transcription factors could explain
miRNA gene expression deregulation we characterized the
promoter regions of co-regulated miRNAs (35). The
results showed that in addition to REST, p53 regulatory
Table 2. HD-deregulated miRNAs
MiRNA Expression
pattern in HD
(sequencing
data)
Expression
pattern in HD
(miRNA
arrays)
Expression
pattern in HD
(miRNA
qRT-PCR)
hsa-let-7g UP UP
hsa-miR-100 UP UP UP
hsa-miR-101 UP –
hsa-miR-106b UP UP
hsa-miR-1250 UP NA
hsa-miR-126 UP –
hsa-miR-126* UP DOWN
hsa-miR-1308 UP NA
hsa-miR-143 UP DOWN
hsa-miR-145 UP –
hsa-miR-146a UP –
hsa-miR-148b UP UP
hsa-miR-151-3p UP UP UP
hsa-miR-151-5p UP UP
hsa-miR-15a UP UP
hsa-miR-15b UP UP
hsa-miR-16 UP UP UP
hsa-miR-17 UP UP
hsa-miR-181a UP UP
hsa-miR-181a* UP UP
hsa-miR-193b UP UP
hsa-miR-197 UP DOWN
hsa-miR-1974 UP NA
hsa-miR-199b-3p UP UP
hsa-miR-19b UP UP
hsa-miR-204 UP UP
hsa-miR-20a UP UP
hsa-miR-219-2-3p UP UP UP
hsa-miR-219-5p UP UP
hsa-miR-22 UP DOWN
hsa-miR-23a UP –
hsa-miR-27b UP UP UP
hsa-miR-29c* UP DOWN
hsa-miR-30a UP DOWN
hsa-miR-30b UP –
hsa-miR-30c UP UP
hsa-miR-30e UP –
hsa-miR-338-3p UP UP
hsa-miR-33a UP UP
hsa-miR-33b UP UP
hsa-miR-363 UP UP
hsa-miR-374a* UP –
hsa-miR-451 UP UP UP
hsa-miR-484 UP DOWN
hsa-miR-486-5p UP UP
hsa-miR-574-3p UP DOWN
hsa-miR-664 UP NA
hsa-miR-887 UP UP
hsa-miR-92a UP UP UP
hsa-miR-93 UP UP
hsa-miR-99b UP UP
hsa-let-7a DOWN –
hsa-let-7c DOWN –
hsa-let-7d DOWN –
hsa-let-7e DOWN –
hsa-miR-103 DOWN DOWN
hsa-miR-107 DOWN DOWN
hsa-miR-1224-5p DOWN NA
hsa-miR-124 DOWN DOWN
hsa-miR-127-3p DOWN DOWN
hsa-miR-128 DOWN DOWN DOWN
hsa-miR-1301 DOWN NA
hsa-miR-1307 DOWN NA
hsa-miR-139-3p DOWN DOWN DOWN
hsa-miR-181d DOWN DOWN
(continued)
Table 2. Continued
MiRNA Expression
pattern in HD
(sequencing
data)
Expression
pattern in HD
(miRNA
arrays)
Expression
pattern in HD
(miRNA
qRT-PCR)
hsa-miR-193b* DOWN –
hsa-miR-199a-3p DOWN NA
hsa-miR-221 DOWN DOWN
hsa-miR-222 DOWN DOWN DOWN
hsa-miR-323-3p DOWN DOWN
hsa-miR-330-3p DOWN UP
hsa-miR-369-5p DOWN DOWN
hsa-miR-382 DOWN DOWN DOWN
hsa-miR-383 DOWN DOWN –
hsa-miR-409-5p DOWN DOWN
hsa-miR-423-5p DOWN –
hsa-miR-432 DOWN DOWN
hsa-miR-433 DOWN DOWN DOWN
hsa-miR-485-3p DOWN DOWN DOWN
hsa-miR-485-5p DOWN DOWN
hsa-miR-92b* DOWN –
hsa-miR-495 DOWN DOWN
hsa-miR-543 DOWN DOWN
hsa-miR-598 DOWN DOWN
hsa-miR-708 DOWN –
hsa-miR-760 DOWN UP
hsa-miR-95 DOWN DOWN
The differential expression in the sequenced samples considers miRNAs
commonly deregulated in HD-FC and HD-ST >1.2 and <–1.2.
P<0.05 (Z-test, Hochberg and Benjamini correction).
The reference miRNA and all the variants mapping on the same
miRNA locus are considered in this analysis.
Only sequences with a normalized frequecy cutoff above 50 (norm freq
C-FC+norm freq HD-FC>50) and (norm freq C-ST+norm freq
HD-ST >50) were included.
In the miRNA arrays, a fold change above 1.2 and below –1.2 in
absolute value was considered.
The results showing a false discovery rate-adjusted P-value (FDR)
below % are highlighted in black, and those with a P>10% are
shown in light gray.
Selected miRNAs (seven uregulated and seven downregulated) were
chosen for validation by RT-PCR.
The signifﬁcantly deregulated miRNAs (P<0.01) are highlighted in
black.
( ) Means that no deregulation was found.
(NA) Means that the miRNA was not available in the array.
In bold, the miRNAs with a more consistent deregulation pattern using
different techniques in additional samples are shown.
7228 Nucleic Acids Research, 2010,Vol.38, No. 20motifs are signiﬁcantly enriched in the promoter region of
the downregulated miRNAs in the FC (Table S13).
Putative targets of HD deregulated miRNAs and seed-
region IsomiRs
We focused on the possible biological pathways affected
by HD-deregulated miRNAs and seed-region IsomiRs.
In this analysis we included miRNA/IsomiRs commonly
upregulated or downregulated in the FC and ST (Table 3
and Supplementary Tables S8 and S9). We ﬁrst identiﬁed
putative targets for the differentially expressed miRNAs
and IsomiRs using the TargetScan 5.1 algorithm that
predicts biological targets of miRNAs or IsomiRs by
searching for the presence of conserved 8-mer and 7-mer
sites that match the seed region of each miRNA/IsomiR
(33,34). Since the cooperative action of multiple miRNAs
can be multiplicative and sometimes synergic (33),
mRNAs with more predicted target sites for co-expressed
miRNAs/IsomiRs should be more drastically affected.
Therefore, we considered targets predicted by three or
more HD-upregulated or HD-downregulated miRNAs/
IsomiRs. Based on these parameters we identiﬁed 45
(HD-enriched) and 40 (HD-diminished) signiﬁcantly
deregulated seed regions that corresponded to 55 and 43
miRNA/IsomiRs, respectively. The number of targets
common to a minimum of three co-regulated miRNAs/
IsomiRs was 1922 for HD-enriched and 1244 for
HD-diminished miRNAs/IsomiRs. It is worth noting
that the two lists of genes showed a signiﬁcant overlap,
Table 3. HD-deregulated seed region isomiRs, >1,2 or <–1,2 fold change, P<0.05 (Z-test, Hochberg and Benjamini correction)
Locus Type of
variant
Seed region Norm freq
HD-FC
Norm freq
CFC
HD-FC
(P<0.05)
Norm
freq HD-ST
Norm
freq CST
HD-ST
(P<0.05)
has-miR-101 50 trimming IsomiR UACAGUA 3972 2421 UP 3258 1955 UP
Ref. miRNA ACAGUAC
has-miR-124 nt- substitution IsomiR AAGGCAA 75 48 UP 26 70 DOWN
Ref. miRNA AAGGCAC
has-miR-124 50 trimming IsomiR UAAGGCA 751 928 DOWN 196 503 DOWN
Ref. miRNA AAGGCAC
has-miR-124 50 trimming IsomiR AGGCACG 139 125 – 41 84 DOWN
Ref. miRNA AAGGCAC
has-miR-126 50 trimming IsomiR GUACCGU 163 131 – 189 83 UP
Ref. miRNA CGUACCG
has-miR-1307 50 trimming IsomiR UCGGCGU 47 82 DOWN 47 65 –
Ref. miRNA CUCGGCG
has-miR-1308 nt- substitution IsomiR CAUUGGU 241 64 UP 365 240 UP
Ref. miRNA CAUGGGU
has-miR-139-3p 50 trimming IsomiR GGAGACG 226 667 DOWN 56 367 DOWN
Ref. miRNA GAGACGC
has-miR-140-3p 50 trimming IsomiR CCACAGG 5751 4051 UP 3396 3703 DOWN
Ref. miRNA ACCACAG
has-miR-142-5p 50 trimming IsomiR CCAUAAA 67 38 UP 46 49 –
Ref. miRNA AUAAAGU
has-miR-192 50 trimming IsomiR GACCUAU 0 51 DOWN 36 37 –
Ref. miRNA UGACCUA
has-miR-1974 50 trimming IsomiR UGGUUGU 126 51 UP 94 69 –
Ref. miRNA GGUUGUA
has-miR-1974 50 trimming IsomiR GUUGUAG 45 24 UP 47 33 –
Ref. miRNA GGUUGUA
has-miR-1979 50 trimming IsomiR CCCACUG 42 27 UP 56 34 UP
Ref. miRNA UCCCACU
has-miR-199a-3p 50 trimming IsomiR ACAGUAG 4 71 DOWN 0 40 DOWN
Ref. miRNA CCAGUGU
has-miR-199b-3p 50 trimming IsomiR ACAGUAG 66 0 UP 49 10 UP
Ref. miRNA CCAGUGU
has-miR-323-3p 50 trimming IsomiR CACAUUA 104 197 DOWN 70 143 DOWN
Ref. miRNA ACAUUAC
has-miR-330-3p 50 trimming IsomiR AAAGCAC 907 1138 DOWN 761 1017 DOWN
Ref. miRNA CAAAGCA
has-miR-330-3p 50 trimming IsomiR AAGCACA 240 323 DOWN 186 222 –
Ref. miRNA CAAAGCA
has-miR-342-3p 50 trimming IsomiR CACACAG 70 50 – 0 62 DOWN
Ref. miRNA CUCACAC
has-miR-411 50 trimming IsomiR UAGUAGA 85 88 – 29 53 DOWN
Ref. miRNA AGUAGAC
has-miR-485-3p 50 trimming IsomiR GUCAUAC 22 47 DOWN 12 25 DOWN
Ref. miRNA UCAUACA
has-miR-935 50 trimming IsomiR AGUUACC 365 296 UP 100 169 DOWN
Ref. miRNA CAGUUAC
The seed region of the miRNAs in gray should be considered as the only representatives among all the isomiRs mapping in the same locus; for these
miRNAs no reference seed region was sequenced.
Nucleic Acids Research, 2010,Vol.38, No. 20 7229suggesting that some genes can be putatively targeted by
sets of unique HD up and downregulated miRNAs.
The IPA tool was used for the subsets of genes affected
by the HD-enriched or HD-downregulated miRNAs/
IsomiRs. The most enriched biological and disease
processes and canonical pathways amongst the
HD-enriched or HD-diminished miRNA/IsomiR targets
are provided in Table 5. Some of the top functional
groups, including genetic disorder, neurological disease,
developmental disorders, cell-to-cell signaling and
Table 4. Expression deregulation of known and predicted REST-modulated miRNAs expressed in brain samples
Locus miR/isomiR HD-FC versus
C-FC (P<0.05)
HD-ST versus
C-ST (P<0.05)
REST modulated
hsa-miR-124 Ref. – DOWN EMSA/ChIP (17) RE1 motive (50)
hsa-miR-124 NA DOWN DOWN
hsa-miR-124 s:10AC – DOWN
hsa-miR-124 s:19UC DOWN DOWN
hsa-miR-124 s:8AC – DOWN
hsa-miR-124 tr5:(down)U DOWN DOWN
hsa-miR-29a NA UP UP EMSA/ChIP (17) RE1 motive (50)
hsa-miR-29a Ref. UP DOWN
hsa-miR-29b NA UP UP EMSA/ChIP (17) RE1 motive (50)
hsa-miR-29b Ref. UP UP
hsa-miR-9 NA UP UP EMSA/ChIP (17) RE1 motive (50)
hsa-miR-9 Ref. DOWN UP
hsa-miR-132 NA – – EMSA/ChIP (17) RE1 motive (50)
hsa-miR-132 Ref. UP –
hsa-miR-212 NA UP – EMSA/ChIP (17) RE1 motive (50)
hsa-miR-139-5p NA UP DOWN EMSA/ChIP (17) RE1 motive (50)
hsa-miR-139-5p Ref. – DOWN
hsa-miR-139-5p tr5:(up)GG UP –
hsa-miR-139-3p tr5:(down)U DOWN DOWN
hsa-miR-133a NA – – EMSA (17)
hsa-miR-203 NA – – EMSA/ChIP (17)
hsa-miR-204 NA UP UP EMSA/ChIP (17)
hsa-miR-204 Ref. UP UP
hsa-miR-330-3p NA – DOWN EMSA/ChIP (17)
hsa-miR-330-3p Ref. – DOWN
hsa-miR-330-3p tr5:(up)G DOWN DOWN
hsa-miR-330-3p tr5:(up)GC DOWN
hsa-miR-346 NA – – EMSA/ChIP (17) RE1 motive (50)
hsa-miR-218 NA – DOWN EMSA/ChIP (17)
hsa-miR-95 NA – – RE1 motive (50)
hsa-miR-95 Ref. DOWN DOWN
hsa-miR-1 Ref. DOWN DOWN Chromatin IP (49)
hsa-miR-153 NA – – RE1 motive (50)
hsa-miR-455 NA – – RE1 motive (50)
hsa-miR-146b-5p NA DOWN – RE1 motive (4)
hsa-miR-1179 NA – – RE1 motive (4)
hsa-miR-1301 NA DOWN DOWN RE1 motive (4)
hsa-miR-1301 Ref. DOWN DOWN
hsa-miR-129-3p NA UP – RE1 motive (4)
hsa-miR-129-3p Ref. UP –
hsa-miR-129-3p s:20UC UP –
hsa-miR-129-5p NA DOWN –
hsa-miR-129-5p Ref. DOWN –
hsa-miR-7 NA DOWN – RE1 motive (4)
hsa-miR-7 Ref. DOWN UP
hsa-miR-137 NA – DOWN RE1 motive (4)
hsa-miR-137 Ref. – DOWN
hsa-miR-184 Ref. – DOWN RE1 motive (4)
hsa-miR-1224-5p NA DOWN DOWN RE1 motive (4)
hsa-miR-940 NA – – RE1 motive (4)
hsa-miR-375 NA – – RE1 motive (4)
hsa-miR-328 NA UP – RE1 motive (4)
hsa-miR-328 Ref. UP –
(–) no differential expression was found in the present study; Ref, reference miRNA; tr5, 50-trimming variants; (up) and (down) followed by the
indictaed nucleotides show the short sequence involved in the trimming variants, upstream and downstream of the corresponding reference miRNA
terminus, respectively; s, shows a nucleotide subtitution variant.
The position of the nucleotide and the pattern of the modiﬁcation is shown next. NA, considers, for differential expression analysis, all the sequences
mapping onto a speciﬁc miRNA locus different from the reference miRNA or the trimming variants, when these are shown in a separate row.
miRNAs in gray did not show signiﬁcant expression changes.
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development and function and organ development were
common between the two groups of miRNAs/IsomiRs,
which is in agreement with the signiﬁcant overlap of the
predicted mRNA targets. HD was identiﬁed as one of the
signiﬁcant canonical pathways (P=6.6E-03) for the
predicted HD-downregulated miRNAs/IsomiRs (Figure
S5). Interestingly, 16 out of the 30 predicted targets
involved HD-canonical pathway are signiﬁcantly
deregulated in HD, as shown in the study by Hodges
et al. (1). Ten out of these 16 mRNAs were upregulated
(Supplementary Table S14), suggesting that the
downregulation of speciﬁc miRNAs could directly con-
tribute to the aberrant increase in the expression of
genes relevant in HD pathways. In line with this, the
amount of predicted targets of the downregulated miRs/
IsomiRs that overlaps with the upregulated mRNAs (1)
was signiﬁcantly enriched (9%, P=0.004, Boostrapping
method) compared with the predicted targets of the
randomly selected miRs/IsomiRs expressed in the brain.
The TarBase of experimentally supported targets for
several miRNAs (http://diana.cslab.ece.ntua.gr/tarbase/)
conﬁrmed a similar idea (Table S15). Considering the
available validated targets of the HD-downregulated
miRNAs, the number of overlapping HD-upregulated
genes in the Hodges et al. (1) study (a total of 62) was
clearly increased compared with that of the
HD-downregulated genes (a total of 7).
To gain insights into the biological pathways possibly
affected by isomiR expression deregulation, we run a
speciﬁc IPA for the predicted targets of the seed-region-
HD-deregulated IsomiRs (Table 3). The results revealed a
signiﬁcant enrichment in genes involved in neurological
diseases for both HD-enriched and HD-diminished
seed-region isomiR targets (Supplementary Table S16).
Furthermore, the HD canonical pathway was signiﬁcantly
enriched for the HD-downregulated seed region isomiR
targets. These results underline the possible contribution
of the IsomiRs in the modulation of HD related pathways.
DISCUSSION
Here, we report the ﬁrst unbiased analysis of small RNA
populations of two different brain areas of healthy indi-
viduals and individuals with HD. Deep sequencing of
small RNAs from the human brain revealed length and
sequence heterogeneity for the vast majority of miRNAs,
indicating that the miRNA transcriptome is more complex
than previously described. However, the fact that the pro-
portion of the different types of variants was found to be
similar in all brain samples agrees with the concept that
the molecular mechanisms involved in the generation of
these variants are not altered in HD.
miRNA variability (IsomiRs) has recently been
described using several large-scale sequencing strategies
in plants (45,46), mouse and human stem cells (37,51),
and human brain samples (47). Our analysis revealed
that IsomiRs are also present in human and mouse
Ago-IPs, suggesting that they are functional as gene ex-
pression modulators. We have found 20000–23000 differ-
ent variants with a frequency >3 in every brain sample.
Our study permits several generalizations regarding the
types of miRNA variants in the human brain, irrespective
of HD neuropathology. Around 80–90% of the miRNAs
presented modiﬁcations in the 30-terminus either in the
form of trimming and/or as nucleotide addition variants.
Table 5. Top biological functions and canonical pathways for
predicted targets of HD-deregulated miRNAs and seed
region-isomiRs: IPA analysis
P-value No. of Molecules
Top biological functions for predicted targets of HD-upreguated miRNAs and
isomiRs
Disease and disorders
Genetic disorder 1.11E-03 - 2.02E-02 36
Neurological disease 1.11E-03 - 4.10E-02 92
Psychological disorders 1.11E-03 - 1.11E-03 34
Developmental disorder 1.02E-02 - 2.02E-02 9
Skeletal and muscular disorders 2.29E-02 - 2.29E-02 3
Molecular and cellular functions
Cellular movement 7.59E-05 - 4.26E-02 24
Cell morphology 1.77E-04 - 2.82E-02 27
Cellular assembly and
organization
2.20E-04 - 2.02E-02 27
Cell-to-cell signalling and
interaction
3.05E-04 - 2.75E-02 17
Cellular growth and
prolifferation
3.88E-04 - 2.29E-02 18
Physiological system development and function
Nervous system development
and function
2.00E-05 - 4.19E-02 97
Organ development 3.18E-04 - 2.29E-02 17
Tissue morphology 6.08E-03 - 2.82E-02 26
Organ morphology 2.02E-02 - 2.02E-02 2
Embryonic development 2.29E-02 - 2.29E-02 3
Top canonical pathways for predicted targets of HD-upreguated miRNAs and
isomiRs
Axonal guidance signaling 3.13E-07 79/320
TGF-b signaling 3.94E-07 27/70
Glioma signaling 4.11E-07 32/91
Molecular mechanisms
of cancer
6.41E-07 75/304
B cell receptor signaling 7.57E-07 38/120
Top biological functions for predicted targets of HD-downreguated miRNAs
and isomiRs
Disease and disorders
Neurological disease 9.57E-04 - 4.75E-02 28
Developmental disorder 8.64E-03 - 4.56E-02 7
Genetic disorder 2.11E-02 - 2.11E-02 3
Skeletal and muscular
disorders
4.56E-02 - 4.56E-02 2
Molecular and cellular functions
Cellular movement 1.27E-04 - 4.40E-02 19
Cellular development 7.85E-04 - 4.42E-02 15
Cell-to-cell signaling
and interaction
9.57E-04 - 2.43E-02 13
Cell death 1.41E-03 - 3.24E-02 24
Cellular growth and proliferation 1.51E-03 - 2.42E-02 13
Physiological system development and function
Nervous system development
and function
8.05E-05 - 4.56E-02 65
Organ development 8.05E-05 - 8.05E-05 12
Tissue development 8.02E-04 - 8.64E-03 5
Embryonic development 1.97E-03 - 2.11E-02 8
Tissue morphology 6.39E-03 - 4.22E-02 17
Top canonical pathways for predicted targets of HD-downregulated miRNAs
and isomiRs
Molecular mechanisms
of cancer
9.65E-07 55/304
GNRH signaling 2.80E-06 27/112
Renal cell carcinoma
signaling
1.05E-05 18/63
PTEN signaling 1.30E-05 21/82
PPARa/RXRa activation 1.61E-05 29/136
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the same miRNA locus, the 30-terminus variants presented
a higher proportion with respect to the reference miRNA.
This is consistent with the idea that variability in the
30-terminus of the miRNA is more permissive, having
minor consequences in gene expression regulation. In
contrast, our analysis displayed a decreased proportion
of miRNAs with heterogeneity at the 50-terminus,
showing the majority of these variants a negligible abun-
dance as compared with that of the reference sequence.
This suggests that the 50 terminus of the miRNAs is spe-
cially protected from variations, which agrees with the
crucial role of Watson–Crick base pairing of the 50-seed
region of the miRNA with the 30UTR of the mRNA, for
gene targeting (43,44).
In accordance with previous reports (41,52,53), variabil-
ity in the 30-terminus was detected as an A or U single
nucleotide extension. These modiﬁcations could inﬂuence
mRNA expression regulation, since 30-end pairing has
been suggested to contribute to target recognition, par-
ticularly when sites have weaker miRNA seed matches
(54,55). In plants, it has been shown that addition of A
residues to the 30-end plays a negative role in miRNA
degradation (56). In addition, it has been proposed that
the combined effects of 50 deletions and 30 U extensions in
Oryza sativa and Arabidopsis thaliana can alter the speci-
ﬁcity by which miRNAs associate with different
Argonaute proteins (45). Whether short nucleotide exten-
sions in animal miRNAs inﬂuence their stability or the
silencing mechanism needs to be proven. However,
recent data show selective stability for different miRNAs
in human cells that depends on regions of the 30-terminus
(57). Differences in the stability could provide an explan-
ation for the discordant expression deregulation of some
30-trimming variants and the corresponding reference
miRNAs.
Our analysis highlights signiﬁcant nucleotide modiﬁca-
tions along the reference mature miRNAs. Several lines of
evidence argue against RT-PCR and sequencing errors as
contributors to sequence discrepancies with respect to the
reference miRNAs. First, the frequencies of nucleotide
modiﬁcations were remarkably higher compared to the
estimates attributable to Illumina sequencing errors (27).
Second, we observed a positional non-randomness of nu-
cleotide changes along the length of the miRNA seen in all
libraries. Third, analogous nucleotide modiﬁcations were
found in four independent libraries. Fourth, several nu-
cleotide substitution variants found in the brain have been
reported in independent sequencing experiments in human
samples. Finally, nucleotide changes, insertions and dele-
tions have been reported in previous studies using differ-
ent sequencing strategies.
Nucleotide substitutions have been described in few
miRNAs as pri-miR precursor editing changes from A
to G attributed in part to A to I deaminations, which
lead to a repression in the maturation of the miRNA
(38–41,45,58). Edited adenosines have been also described
in mature miRNAs (38–40). Our results not only have
conﬁrmed the existence of these variants, but also show
that an A to G change is one of the most common types of
nucleotide substitution events in the seed region.
However, a considerable proportion of brain miRNAs
presented nucleotide changes that were distinct from the
classical A to I editing. Common nucleotide substitutions
in brain miRNAs included U to G, C to A, G to A and G
to U changes. These patterns of nucleotide modiﬁcations
have been recently shown in miRNAs and tRNAs of
plants (45) and in the let family of miRNAs in different
mouse cell lines (48). In animals, these modiﬁcations in the
mature miRNA may result in alternative base pairing
between the variant and the target mRNA, possibly af-
fecting the efﬁciency and/or quality of gene expression
regulation (59). This has been shown human miR-376a
that presents an A to G editing event in the seed region
that affects gene targeting (40). Another example has been
recently reported in the mouse let-7 family of miRNAs, as
several types of nucleotide modiﬁcations at the ninth
position of mmu-let7a result in an increase of the stability
of the predicted miRNA:mRNA duplexes (48).
We have found that the detected nucleotide substitution
events are not randomly distributed along the sequence.
The less variable positions present key roles in gene target
recognition and silencing. For instance, scarce miRNAs
presented nucleotide substitutions at positions 2–4 of the
miRNA within the 50-seed region (nt 2–8). A contiguous
and perfect base pairing of the miRNA nucleotides 2–8,
representing the seed region, is the most stringent require-
ment for efﬁcient target recognition (44,54). In addition,
low variability was detected at positions 14–16, contained
in an anchor site (nt 13–16) that has been proposed to
hold important determinants for miRNA:mRNA associ-
ation. However, positions 9–12 of the miRNA were
amongst the more variable, which could contribute to
the imperfect mRNA:miRNA pairing detected in the
central region of the miRNA. For gene expression repres-
sion, bugles or mismatches must be present in the central
region of the miRNA:mRNA duplex (nt 9–12 of the
miRNA), precluding the Argonaute-mediated
endonucleolytic cleavage of mRNA (44). All together,
the present analysis strongly suggests a biological
function for this sequence plasticity in miRNAs, which
may have broad implications in mRNA targeting, stability
and/or gene expression regulation mechanism.
HD is characterized by widespread changes in neuronal
gene expression (1,60). Recent studies have shown
that the miRNA transcriptome is also perturbed in HD
(17,18) affecting miR-9/9*, miR-124a, miR-132, miR-29b,
miR-29a, miR-330, miR-17, miR-196a, miR-222, miR-485
and miR-486. Although further miRNA sequencing of
HD brain samples will provide a comprehensive picture
of the myriad of small RNAs in this disorder, our results
conﬁrm the deregulation pattern for 9 out of the 11
miRNAs, but also suggested that miRNA expression de-
regulation is more extensive in HD, affecting a consider-
able number of miRNAs and IsomiRs. Alterations in the
miRNA/isomiR transcriptome may contribute to the
aberrant expression of downstream genes detected in
HD. In line with this, the putative targets of the
HD-deregulated miRNAs and/or seed-region IsomiRs
denote that these variants could participate in HD patho-
genesis. It is worth pointing out that HD canonical
pathway was among the signiﬁcantly enriched pathways
7232 Nucleic Acids Research, 2010,Vol.38, No. 20for the HD-downregulated miRs and/or IsomiRs. In
addition, the study by Hodges et al. (1) shows that
many HD-downregulated genes may underlie a defect in
the capacity to maintain axonal projections. In agreement,
our analysis revealed that axonal guidance signaling and
actin and cytoskeleton signaling were among the highly
signiﬁcantly enriched pathways for the predicted targets
of the upregulated miRNAs.
A large number of miRNAs presented the same deregu-
lation proﬁle in the two studied areas, which show a dif-
ferent pattern of neuronal loss, similarly to what has been
reported in gene expression analysis of different brain
areas in HD (1). Therefore, shared deregulated miRNAs
may lie beneath gene expression deregulation linked to the
common neuropathological changes, including neuronal
degeneration, astrocytic gliosis and moderate microglial
proliferation. Since advanced stages of the disease are con-
sidered in the present study, it is feasible that many
changes in the miRNA transcriptome are not linked to
HD-primary episodes, but may be reactive events to
secondary-common processes occurring in neuro-
degeneration, such as oxidative stress. In line with this,
several miRNAs present a similar pattern of deregulation
as that described in other neurodegenerative disorders. In
addition, at advanced stages some of the HD-related tran-
scriptional modiﬁcations, especially gene expression
downregulation, could be caused by changes in the
relative number of neurons linked to selective neuro-
degeneration rather than changes in speciﬁc neuronal
miRNA genes. However, a previous study shows similar
HD-deregulated mRNAs in data sets of brain homogen-
ates and laser capture microdissection that ensures similar
numbers of neurons in control and HD samples (1). These
data suggest that miRNA expression deregulation could
be explained, at least in part, by transcriptional changes
occurring in the remaining cells. The region-speciﬁc
miRNA transcriptome deregulation may account for se-
lective pathophysiological changes in HD, including the
preferential affectation of the gamma-aminobutyric acid
(GABA)ergic spiny neurons in the ST and the projection
neurons in the FC.
Some miRNAs that are in chromosomal clusters ex-
hibited similar expression patterns in HD. For instance,
miR-221 and miR-222 were both downregulated in HD.
In addition, we noted that in some cases, miRNA
members of the same family exhibited similar expression
trends, suggesting their co-regulation in HD. For instance,
let-7a, let-7c, let-7d and let-7e were downregulated in
HD-FC and HD-ST. In another example, miR-30a,
miR-30b, miR-30c and miR-30e were all upregulated in
HD-FC and HD-ST. These results are in agreement with
the idea of a relevant role of certain miRNA families in
HD pathology. An interesting opened question is the
understanding of the mechanisms accounting for the
co-regulation of non-clustered miRNAs of the same
family in pathological processes.
Consistent with both the deregulation of miRNA and
mRNA gene expression in HD, a number of transcription-
al modulators are affected by mutant HTT (61). There is
strong evidence that the abnormal function of the tran-
scriptional repressor REST plays a major role in gene
expression deregulation in HD (2,3). BDNF is a
REST-modulated neuronal gene whose loss in the
striatum of HD patients contributes to the medium
spiny neuronal loss and clinical manifestations of the
disease (3,62). It is interesting that miR-30a, which has
been shown to target BDNF (63), is signiﬁcantly
upregulated in both HD-FC and HD-ST brain samples.
Therefore, in addition to REST, miR-30a upregulation
could contribute to BDNF expression inhibition.
Some neuronal miRNAs modulated by REST
(miR-124, miR-29a, miR-29b, miR9/9* miR-132 and
miR-330-3p) are abnormally expressed in the FC of HD
patients (5,17,18). Taking into account all brain-expressed
miRNAs showing experimental or predictive evidences
for REST modulation (REST-miRNAs) our analysis
identiﬁed a larger number of deregulated REST-
miRNAs. Furthermore, these miRNAs were found to be
enriched among those downregulated in HD brain
regions. Overall, our results agree with the concept that
REST dysfunction generaly alters the miRNA transcrip-
tome in HD, which may inﬂuence the expression of down-
stream targets. In addition, we identiﬁed p53 tumor
supressor as a transcription factor with a putative role in
HD-miRNA deregulation. P53 is found in polyglutamine
aggregates both in vivo and in vitro, suggesting an
hypofunction of p53 in HD (64). Therefore, p53 may con-
tribute to miRNA expression downregulation in HD.
In summary, this study shows that miRNA variability
is a ubiquitous phenomenon in the adult human brain
that may inﬂuence the mechanism of gene silencing or
gene targeting. How the IsomiRs are selectively generated
and the possible speciﬁc role that these variants have in
development, organ physiology or pathological processes,
such as HD, opens a new perspective in the ﬁeld of
miRNAs.
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